Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups

Journal of Viral Hepatitis

Volumn 7, Issue 6, 2000, Pages 435-439

  Krarup, H B ^a,b,c,d   Moller J M ^a,b,c,d   Christensen, P B ^a,b,c,d   Fuglsang, T ^a,b,c,d   Ingerslev, J ^a,b,c,d   Arnfred, T ^a,b,c,d   Madsen, P H ^a,b,c,d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Institution 'Forchhammersvej'   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Genotypes; Haemophilia; Hepatitis C; Post transfusion hepatitis; Viral load

Indexed keywords

ILLICIT DRUG; VIRUS RNA;

ADULT; AGED; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENOTYPE; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; FEMALE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD;

EID: 0033661582     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00258.x     Document Type: Article

References (36)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Detection of hepatitis C viral sequences in non-A, non-B hepatitis
4. Sequence analysis of the 5' noncoding region of hepatitis C virus
5. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants
6. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease
7. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infection
8. Significance of the serum hepatitis C virus RNA levels in chronic hepatitis C
9. Hepatitis C viremia in chronic liver disease: Relationship to interferon-α or corticosteroid treatment
10. Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease
11. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease
12. Viral load in samples from hepatitis C virus (HCV)-infected patients with various clinical conditions
13. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology
14. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection
15. Natural history of liver fibrosis progression in patients with chronic hepatitis C
16. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: A comparison between immunocompetent and immunocompromised patients
17. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA
18. Transfusion-acquired hepatitis C: The Danish lookback experience
19. A quantitative HCV-PCR test for routine diagnostics
20. Interferon-α2b therapy in low-activity hepatitis C. A pilot study
21. Multiple comparisons using ranksums
22. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey
23. Relationship between hepatitis C virus genotypes and sources of infection in chronic hepatitis C
24. Molecular epidemiology of hepatitis C virus infection among intravenous drug users
25. Distribution of HCV genotypes in patients infected by different sources
26. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C
27. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
28. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
29. Randomised trial of interferon alfa-2b and ribavirin for 48 weeks or for 24 weeks versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
30. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b
31. Genotypic analysis of hepatitis C virus in American patients
32. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States
33. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders
34. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV RNA assay, version 1 and 2, roche monitor assay, and an in-house limiting dilution method
35. Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method
36. Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays